BHST
Income statement / Annual
Last year (2024), BioHarvest Sciences Inc. Common Stock's total revenue was $25.19 M,
an increase of 98.77% from the previous year.
In 2024, BioHarvest Sciences Inc. Common Stock's net income was -$12.91 M.
See BioHarvest Sciences Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
04/30/2019 |
04/30/2018 |
04/30/2017 |
04/30/2016 |
| Operating Revenue |
$25.19 M |
$12.67 M |
$5.50 M |
$2.10 M |
$396.00 K |
$218.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$11.25 M
|
$7.04 M
|
$4.28 M
|
$1.43 M
|
$258.00 K
|
$189.00 K
|
$0.00
|
$0.00
|
$482.70
|
$0.00
|
| Gross Profit |
$13.94 M
|
$5.63 M
|
$1.22 M
|
$670.00 K
|
$138.00 K
|
$29.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.55
|
0.44
|
0.22
|
0.32
|
0.35
|
0.13
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$4.80 M
|
$3.37 M
|
$2.31 M
|
$4.13 M
|
$1.26 M
|
$1.35 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$6.47 M
|
$5.68 M
|
$5.05 M
|
$1.80 M
|
$3.95 M
|
$861.00 K
|
$523.00 K
|
$121.03 K
|
$51.88 K
|
$118.52 K
|
| Selling & Marketing Expenses |
$9.26 M
|
$6.40 M
|
$4.30 M
|
$2.96 M
|
$368.00 K
|
$59.00 K
|
-$523.00 K
|
-$121.03 K
|
$3.28 K
|
$8.41 K
|
| Selling, General & Administrative Expenses |
$15.74 M
|
$12.08 M
|
$9.35 M
|
$4.76 M
|
$4.31 M
|
$920.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$399.00 K
|
$154.00 K
|
$171.00 K
|
$273.00 K
|
$726.00 K
|
$73.00 K
|
$4.36 M
|
$160.80 K
|
$93.70 K
|
$127.46 K
|
| Operating Expenses |
$20.93 M
|
$15.60 M
|
$11.83 M
|
$9.16 M
|
$6.30 M
|
$2.34 M
|
$4.36 M
|
$160.80 K
|
$93.70 K
|
$127.46 K
|
| Cost And Expenses |
$32.18 M
|
$22.64 M
|
$16.11 M
|
$10.59 M
|
$6.56 M
|
$2.53 M
|
$4.36 M
|
$160.80 K
|
$93.70 K
|
$127.46 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$131.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.93 M
|
$1.96 M
|
$1.40 M
|
$805.00 K
|
$535.89 K
|
$2.25 M
|
$780.00 K
|
$3.95 K
|
$6.52 K
|
$2.15 K
|
| Depreciation & Amortization |
$1.25 M
|
$840.00 K
|
$712.00 K
|
$385.58 K
|
$288.00 K
|
$331.53 K
|
$0.00
|
$249.91
|
$483.67
|
$525.74
|
| EBITDA |
-$9.72 M |
-$9.76 M |
-$9.13 M |
-$8.64 M |
-$5.77 M |
-$1.98 M |
$0.00 |
-$159.63 K |
-$93.22 K |
-$126.94 K |
| EBITDA Ratio |
-0.39
|
-0.77
|
-1.66
|
-4.11
|
-14.58
|
-9.09
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-0.28
|
-0.79
|
-1.93
|
-4.04
|
-15.57
|
-10.6
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$5.92 M
|
-$2.60 M
|
-$624.00 K
|
-$1.34 M
|
-$418.00 K
|
-$3.00 M
|
$4.36 M
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$12.91 M
|
-$12.56 M
|
-$11.24 M
|
-$9.83 M
|
-$6.58 M
|
-$5.31 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax Ratio |
-0.51
|
-0.99
|
-2.04
|
-4.68
|
-16.63
|
-24.36
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$8.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$12.91 M
|
-$12.56 M
|
-$11.24 M
|
-$9.83 M
|
-$6.58 M
|
-$5.31 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income Ratio |
-0.51
|
-0.99
|
-2.04
|
-4.68
|
-16.63
|
-24.36
|
0
|
0
|
0
|
0
|
| EPS |
-0.8 |
-0.93 |
-0.7 |
-0.7 |
-0.7 |
-1.75 |
-2.34 |
-0.21 |
-0.19 |
-0.44 |
| EPS Diluted |
-0.8 |
-0.93 |
-0.7 |
-0.7 |
-0.7 |
-1.75 |
-2.34 |
-0.21 |
-0.19 |
-0.44 |
| Weighted Average Shares Out |
$16.19 M
|
$13.53 M
|
$13.05 M
|
$12.45 M
|
$9.71 M
|
$2.95 M
|
$1.63 M
|
$578.47 K
|
$416.06 K
|
$393.08 K
|
| Weighted Average Shares Out Diluted |
$16.19 M
|
$13.53 M
|
$13.05 M
|
$12.45 M
|
$9.71 M
|
$2.95 M
|
$1.63 M
|
$578.47 K
|
$416.06 K
|
$393.08 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
